Imaging expression of the human somatostatin receptor subtype-2 reporter gene with 68Ga-DOTATOC

Journal of Nuclear Medicine

Volumn 52, Issue 1, 2011, Pages 123-131

  Zhang, Hanwen ^a   Moroz, Maxim A ^a   Serganova, Inna ^a   Ku, Thomas ^a   Huang, Ruimin ^a   Vider, Jelena ^a   Maecke, Helmut R ^b   Larson, Steven M ^a   Blasberg, Ronald ^a   Smith Jones, Peter M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

68Ga DOTATOC; hSSTr2; PET; Reporter gene

Indexed keywords

GALLIUM 68; GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR; SOMATOSTATIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; GALLIUM RADIOISOTOPES; GENE THERAPY; HUMANS; ISOTOPE LABELING; MALE; MICE; OCTREOTIDE; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 79851501287     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.079004     Document Type: Article

References (40)

1. Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev. 2003;24:389-427. (Pubitemid 37056239)
2. van der Lely AJ, de Herder WW, Krenning EP, Kwekkeboom DJ. Octreoscan radioreceptor imaging. Endocrine. 2003;20:307-311. (Pubitemid 36571034)
3. Bodei L, Ferone D, Grana CM, et al. Peptide receptor therapies in neuroendocrine tumors. J Endocrinol Invest. 2009;32:360-369.
4. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol. 1999;20:157-198. (Pubitemid 29362641)
5. Susini C, Buscail L. Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol. 2006;17:1733-1742. (Pubitemid 44884046)
6. Danesi R, Agen C, Benelli U, et al. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Clin Cancer Res. 1997;3:265-272. (Pubitemid 27107304)
7. Florio T, Morini M, Villa V, et al. Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. Endocrinology. 2003;144:1574-1584. (Pubitemid 36428500)
8. Mentlein R, Eichler O, Forstreuter F, Held-Feindt J. Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells. Int J Cancer. 2001;92:545-550. (Pubitemid 32319428)
9. Florio T. Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors. Front Biosci. 2008;13:822-840.
10. Ludvigsen E, Stridsberg M, Taylor JE, Culler MD, Oberg K, Janson ET. Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells. Med Oncol. 2004;21:285-295. (Pubitemid 39469770)
11. 3-octreotide PET for assessing response to somatostatin-receptor- mediated radionuclide therapy. J Nucl Med. 2009;50:1427-1434.
12. 3- octreotide: first results in patients with meningiomas. J Nucl Med. 2001;42:1053-1056.
13. Serganova I, Ponomarev V, Blasberg R. Human reporter genes: potential use in clinical studies. Nucl Med Biol. 2007;34:791-807. (Pubitemid 47503822)
14. 111In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin Cancer Res. 1999;5:383-393.
15. Kundra V, Mannting F, Jones AG, Kassis AI. Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer. J Nucl Med. 2002;43:406-412. (Pubitemid 34208104)
16. Zinn KR, Buchsbaum DJ, Chaudhuri TR, Mountz JM, Grizzle WE, Rogers BE. Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re. J Nucl Med. 2000;41:887-895. (Pubitemid 30266035)
17. Rogers BE, Parry JJ, Andrews R, Cordopatis P, Nock BA, Maina T. MicroPET imaging of gene transfer with a somatostatin receptor-based reporter gene and 94mTc-demotate 1. J Nucl Med. 2005;46:1889-1897. (Pubitemid 46196652)
18. 3]-octreotide (SMT487): two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man. Bioorg Med Chem Lett. 1998;8:1207-1210.
19. Serganova I, Doubrovin M, Vider J, et al. Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice. Cancer Res. 2004;64:6101-6108. (Pubitemid 39129410)
20. Burns AA, Vider J, Ow H, et al. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett. 2009;9:442-448.
21. Waser B, Tamma ML, Cescato R, Maecke HR, Reubi JC. Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues. J Nucl Med. 2009;50:936-941.
22. Tjuvajev JG, Doubrovin M, Akhurst T, et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med. 2002;43:1072-1083. (Pubitemid 34847932)
23. Che J, Doubrovin M, Serganova I, Ageyeva L, Zanzonico P, Blasberg R. hNIS-IRES-eGFP dual reporter gene imaging. Mol Imaging. 2005;4:128-136. (Pubitemid 43143800)
24. Moroz MA, Serganova I, Zanzonico P, et al. Imaging hNET reporter gene expression with 124I-MIBG. J Nucl Med. 2007;48:827-836. (Pubitemid 47604985)
25. Bushnell D. Treatment of metastatic carcinoid tumors with radiolabeled biologic molecules. J Natl Compr Canc Netw. 2009;7:760-764.
26. Reubi JC, Schar JC, Waser B, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med. 2000;27:273-282. (Pubitemid 30167697)
27. Patel YC, Srikant CB. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology. 1994;135:2814-2817. (Pubitemid 24377451)
28. 99mTc-P829. Cancer Res. 1998;58:1850-1859.
29. Barbieri F, Pattarozzi A, Gatti M, et al. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2. Endocrinology. 2008;149:4736-4746.
30. Zatelli MC, Tagliati F, Taylor JE, Rossi R, Culler MD, degli Uberti EC. Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt. J Clin Endocrinol Metab. 2001;86:2161-2169. (Pubitemid 32472934)
31. Taboada GF, Luque RM, Neto LV, et al. Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR. Eur J Endocrinol. 2008;158:295-303.
32. Vernejoul F, Faure P, Benali N, et al. Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models. Cancer Res. 2002;62:6124-6131. (Pubitemid 35244461)
33. Zhou T, Xiao X, Xu B, Li H, Zou Y. Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways. Acta Oncol. 2009;48:401-410.
34. Elliott DE, Li J, Blum AM, Metwali A, Patel YC, Weinstock JV. SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release. Eur J Immunol. 1999;29:2454-2463. (Pubitemid 29378115)
35. Talme T, Ivanoff J, Hagglund M, Van Neerven RJ, Ivanoff A, Sundqvist KG. Somatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells. Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3. Clin Exp Immunol. 2001;125:71-79.
36. MacLaren DC, Gambhir SS, Satyamurthy N, et al. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 1999;6:785-791. (Pubitemid 29243651)
37. Han L, Yang D, Kundra V. Signaling can be uncoupled from imaging of the somatostatin receptor type 2. Mol Imaging. 2007;6:427-437.
38. Chaudhuri TR, Rogers BE, Buchsbaum DJ, Mountz JM, Zinn KR. A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecol Oncol. 2001;83:432-438. (Pubitemid 33033095)
39. Yang D, Han L, Kundra V. Exogenous gene expression in tumors: noninvasive quantification with functional and anatomic imaging in a mouse model. Radiology. 2005;235:950-958. (Pubitemid 40695894)
40. Singh SP, Yang D, Ravoori M, Han L, Kundra V. In vivo functional and anatomic imaging for assessment of in vivo gene transfer. Radiology. 2009; 252:763-771.